Literature DB >> 3057860

Therapeutic control of oral anticoagulant treatment in The Netherlands.

A M van den Besselaar1, F J van der Meer, C W Gerrits-Drabbe.   

Abstract

Therapeutic control achieved by an anticoagulant clinic may be assessed by calculation of the proportion of time spent by the patients within the prothrombin time target range aimed for by the clinic. Three calculation methods for such assessment have been described by other investigators. The three methods were compared with the use of the database of one anticoagulant clinic (Leiden Thrombosis Centre). Discrepant levels of control were obtained by these methods because of incorrect assumptions in two of them. The most accurate method is the "cross-section-of-the-files" approach, in which the last-recorded prothrombin time per patient is used. The authors believe it should be implemented in each anticoagulant clinic. With the use of this method, the level of therapeutic control achieved by the Leiden Thrombosis Centre for its patients on long-term treatment amounted to 80%. The same method was applied by 37 other thrombosis centers in the Netherlands using a single target range of 2.8-4.8 International Normalized Ratio for their patients. Thirty-one centers achieved a level of control of at least 70% in their long-term patients. Underanticoagulation was observed more frequently than overanticoagulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3057860     DOI: 10.1093/ajcp/90.6.685

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Initiation of warfarin in hospitals.

Authors:  Suhail A R Doi
Journal:  Clin Med Res       Date:  2007-12

2.  Should we just let the anticoagulation service do it? The conundrum of anticoagulation for atrial fibrillation.

Authors:  D B Matchar; G P Samsa; S J Cohen
Journal:  J Gen Intern Med       Date:  1996-12       Impact factor: 5.128

3.  Costs and effectiveness of a nurse specialist anticoagulant service.

Authors:  F C Taylor; A Gray; H Cohen; L Gaminara; M Ramsay; D Miller
Journal:  J Clin Pathol       Date:  1997-10       Impact factor: 3.411

Review 4.  Cognitive impairment as determinant for sub-optimal control of oral anticoagulation treatment in elderly patients with atrial fibrillation.

Authors:  Bob A J van Deelen; Patricia M L A van den Bemt; Toine C G Egberts; Annelies van 't Hoff; Huub A A M Maas
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 5.  Therapeutic target values in oral anticoagulation--justification of Dutch policy and a warning against the so-called moderate-intensity regimens.

Authors:  E A Loeliger
Journal:  Ann Hematol       Date:  1992-02       Impact factor: 3.673

6.  Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range.

Authors:  L Schmitt; J Speckman; J Ansell
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

Review 7.  Role of patient compliance in clinical pharmacokinetics. A review of recent research.

Authors:  J Urquhart
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

8.  Quality of oral anticoagulation with phenprocoumon in regular medical care and its potential for improvement in a telemedicine-based coagulation service--results from the prospective, multi-center, observational cohort study thrombEVAL.

Authors:  Jürgen H Prochaska; Sebastian Göbel; Karsten Keller; Meike Coldewey; Alexander Ullmann; Heidrun Lamparter; Claus Jünger; Zaid Al-Bayati; Christina Baer; Ulrich Walter; Christoph Bickel; Hugo ten Cate; Thomas Münzel; Philipp S Wild
Journal:  BMC Med       Date:  2015-01-23       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.